Results In Drug Studies Follow The M-O-N-E-Y
Category: Seeing Clearly Now
Guess whose drug looks best in drug company-funded studies? That is the question posed by Leigh Hopper at MedBlog. She then quotes from a Washington Post story that confirms our strong suspicions about the integrity of drug studies financed by particular drug manufacturers.
"I have come to believe a lot of inefficiency is quite deliberate and supported by Congress," he said. "One person's inefficiency is another person's income."
I love this kicker quote at the end of a Washington Post story about how studies comparing schizophrenia drugs often favor the drug made by the company funding the study.
In fact, when psychiatrist John Davis analyzed every publicly available trial funded by the pharmaceutical industry pitting five new antipsychotic drugs against one another, nine in 10 showed that the best drug was the one made by the company funding the study.... (E)xperts note that industry studies invariably seek to boost the image of expensive drugs that are still under patent. ...
By contrast, when the federal government recently compared a broader range of drugs in typical schizophrenia patients in a lengthy trial, two medications that stood out were cheaper drugs not under patent.
It shouldn't take a greedy trial lawyer to understand that you have to follow the money.
TrackBack URL for this entry:
Just a word about clozapine. Patients who take clozapine are advised to have a blood cell count every week, for the first 6 months of therapy. After this they should continue to conduct said count every 2 weeks. In addition, a regular echocardiogram is also recommended to detect myocarditis.
These tests alone are an increased cost to the consumer. Additionally, the makers of this medication do not provide samples to physicians in contrast to Lilly and Janssen, who tend to be generous with their supplies of Zyprexa and Risperdal samples, which physicians can provide to their patients at no cost whatsoever.
Posted by: Florida Nurse at April 14, 2006 10:37 PM